Lincluden Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-55,634
Closed -$1.85M 81
2017
Q2
$1.85M Sell
55,634
-26,695
-32% -$826K 0.16% 62
2017
Q1
$2.64M Buy
82,329
+23,475
+40% +$801K 0.24% 59
2016
Q4
$2.13M Buy
58,854
+4,272
+8% +$171K 0.23% 63
2016
Q3
$2.51M Buy
54,582
+735
+1% +$38.3K 0.37% 63
2016
Q2
$2.71M Buy
53,847
+8,017
+17% +$427K 0.45% 58
2016
Q1
$2.45M Buy
45,830
+50
+0.1% +$2.93K 0.41% 60
2015
Q4
$3M Sell
45,780
-1,310
-3% -$81K 0.61% 50
2015
Q3
$2.66M Sell
47,090
-2,940
-6% -$191K 0.51% 52
2015
Q2
$2.96K Sell
50,030
-17,510
-26% -$1.08M 0.36% 47
2015
Q1
$4.21M Buy
67,540
+13,870
+26% +$806K 0.6% 46
2014
Q4
$3.09M Sell
53,670
-27,253
-34% -$1.52M 0.3% 58
2014
Q3
$4.35M Buy
80,923
+1,809
+2% +$95.8K 0.42% 52
2014
Q2
$4.15M Buy
79,114
+9,518
+14% +$486K 0.38% 57
2014
Q1
$3.68M Sell
69,596
-10,502
-13% -$485K 0.35% 56
2013
Q4
$3.21M Buy
80,098
+6,207
+8% +$244K 0.29% 57
2013
Q3
$2.79M Buy
+73,891
New +$2.88M 0.35% 55

Other funds holding TEVA